CBUM:XETRA:XETRA-iShares S&P 500 ESG UCITS ETF EUR Hedged (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.698

Change

-0.03 (-0.45)%

Market Cap

N/A

Volume

5.08K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.08 (+0.17%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.18%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.21%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.07 (+0.27%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.24 (-0.89%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.08 (+0.16%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.10 (+0.77%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.04 (+0.15%)

USD 79.79B

ETFs Containing CBUM:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.95% 90% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.95% 90% A- 86% B+
Trailing 12 Months  
Capital Gain 23.99% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.99% 88% B+ 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.83% 72% C 69% C-
Dividend Return 9.83% 71% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.84% 52% F 62% D
Risk Adjusted Return 83.04% 89% A- 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike